[ACL] YoY Quarter Result on 30-Sep-2022 [#Q1]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q1]
Profit Trend
QoQ- -73.54%
YoY- -80.48%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 168,634 180,156 269,001 158,952 129,850 6.74%
PBT 3,903 16,378 92,472 40,637 -100 -
Tax 1,366 3,637 27,328 12,101 50 128.49%
NP 2,476 12,711 65,107 28,537 -50 -
Tax Rate -34.99% -22.21% -29.55% -29.78% - -
Total Cost 166,158 167,446 203,894 130,416 129,900 6.34%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 1.47 7.06 24.20 17.95 -0.04 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS 0.01 0.06 0.32 0.20 0.00 -
EPS Diluted 0.01 0.06 0.32 0.20 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.